🇺🇸 FDA
Patent

US 6723338

Compositions and methods for treating lymphoma

expired A61KA61K31/475A61K31/704

Quick answer

US patent 6723338 (Compositions and methods for treating lymphoma) held by The Board of Regents of the University of Texas System expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/475, A61K31/704, A61K9/127, A61K9/1278